Table 1.
Patient characteristics
| Pre-lockdown era | COVID-19-lockdown era | p value | |
|---|---|---|---|
| Patient characteristics | N = 252 | N = 101 | |
| Gender (f), n (%) | 147 (58) | 49 (49) | 0.093 |
| Median age, years (range) | 72 (24–96) | 68 (29–90) | 0.835 |
| BMI, kg/m2 (±SD) | 26 (±5.0) | 27 (±5.6) | 0.870 |
| Elective cases, n (%) | 147 (62) | 39 (39) | <0.001 |
| Indication for CCE, n (%) | |||
| Acute cholecystitis | 87 (35) | 53 (52) | |
| CDL/pancreatitis | 49 (19) | 17 (17) | 0.006 |
| Symptomatic cholecystolithiasis | 116 (46) | 31 (31) | |
| ERC prior to CCE, n (%) | 50 (20) | 27 (27) | 0.156 |
| Median time between ERC and CCE, days (±SD) | 9 (±96) | 4 (±18) | 0.006 |
| Laparoscopic CCE, n (%) | 225 (90) | 92 (91) | 0.771 |
| Open CCE, n (%) | 25 (10) | 9 (9) | |
| Cholangiography, n (%) | 7 (3) | 1 (1) | 0.448 |
CDL, choledocholithiasis; ERC, endoscopic retrograde cholangiography; CCE, cholecystectomy; BMI, body mass index. Table 1 displays the patient characteristics of the study populations both before the lockdown (2018 & 2019) and during the COVID-19 lockdowns (2020).